Background The mechanisms by which any upper respiratory virus, including SARS-CoV-2,
impairs chemosensory function are not known. COVID-19 is frequently associated with …

Long-COVID is a postviral illness that can affect survivors of COVID-19, regardless of initial
disease severity or age. Symptoms of long-COVID include fatigue, dyspnea, gastrointestinal …

COVID-19 has resulted in more than 120 million cases and 2.6 million deaths to date.
Respiratory and gastrointestinal symptoms are accompanied by short-and long-term …

Many patients with SARS-CoV-2 infection develop neurological signs and symptoms;
although, to date, little evidence exists that primary infection of the brain is a significant …

There is growing evidence that excessive microglial phagocytosis of neurons and synapses
contributes to multiple brain pathologies. RNA‐seq and genome‐wide association (GWAS) …

Abstract SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2), the new
coronavirus responsible for the pandemic disease in the last year, is able to affect the central …

Background Neurological symptoms such as cognitive decline and depression contribute
substantially to post-COVID-19 syndrome, defined as lasting symptoms several weeks after …

Abstract Coronavirus disease 2019 (COVID-19) is emerging as the greatest public health
crisis in the early 21 st century. Its causative agent, Severe Acute Respiratory Syndrome …

Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection causes various neurological symptoms in patients with coronavirus …

Neurological symptoms, including cognitive impairment and fatigue, can occur in both the
acute infection phase of coronavirus disease 2019 (COVID-19) and at later stages, yet the …